|
|
by John Steuart on May 14th, 2012 
On Wednesday May 16 I will be presenting at the iMedicine & Mobile Life Sciences World Summit concerning smartphones as the next frontier in medical imaging, telemedicine and EMRs. I am presenting with Tobin Arthur of Cureus. Cureus is revolutionizing medical publishing and is founded by John Adler, a famous neurosurgeon at Stanford. Physicians today use their smartphones 5 times a day on average and these smartphones are another form of clinical decision support . . .
→ Read full post: Smartphones as the Next Frontier in Medical Imaging, EMRs and Telemedicine
by Claremont Creek Alerts on April 25th, 2012 
http://youtu.be/xn8LdxmSfSk
On March 20, 2012, the Lester Center for Entrepreneurship proudly recognized biotech pioneer Moshe Alafi with its 2012 Lifetime Achievement Award at a special awards dinner. A Berkeley alumnus, Mr. Alafi is one of the founders of the biotechnology industry. He has funded and helped start over 60 companies through his venture capital firm Alafi Capital. Many of these firms have created entire new industries including such pioneers as Cetus, Biogen, Applied Biosystems, and Amgen. His life is an incredible inspiration to entrepreneurs as a successful investor and startup partner as well as one who has done an incredible amount to improve our health and scientific knowledge with biotechnology breakthroughs. . . .
→ Read full post: Moshe Alafi wins Lifetime Achievement Award — videos of event
by Claremont Creek Alerts on March 24th, 2012 
by Nat Goldhaber and John Steuart
Moshe Alafi, a former mentor to both of us and investor in our startups earlier in our career, won the Lifetime Achievement Award at the Haas School’s Lester Center for Entrepreneurship at UC Berkeley last week. There wasn’t any doubt that he fully deserved to win this highly prestigious award.
Moshe, after all, has been called one of the founders of biotechnology. We believe he is the most successful . . .
→ Read full post: Biotech Industry Guru Moshe Alafi Wins Lifetime Achievement Award From UC Berkeley
by Claremont Creek Alerts on March 14th, 2012 
http://vimeo.com/38536736
On Tuesday, March 20, 2012, the Lester Center for Entrepreneurship will proudly bestow its 2012 Lifetime Achievement Award in Entrepreneurship to Moshe Alafi, Founder and Principal of Alafi Capital Company LLC.
The Lester Center for Entrepreneurship at the Haas School of Business, University of California Berkeley is proud to honor Moshe Alafi with its Lifetime Achievement Award. A Berkeley alumnus, Mr. Alafi is one of the founders of the biotechnology industry. He has funded and . . .
→ Read full post: Moshe Alafi – Lifetime Achievement Award Trailer video
by John Steuart on March 9th, 2012
Moshe Alafi will be presented with the Lifetime Achievement in Entrepreneurship Award for 2012 by the Lester Center for Entrepreneurship at the Haas School of Business, University of California Berkeley on Tuesday, March 20th. Moshe has been a mentor to me and Claremont Creek Ventures is proud to be a sponsor of this event.
You may register to join us on March 20, 2012. The award dinner will take place at The Great Hall . . .
→ Read full post: Moshe Alafi honored with the Lifetime Achievement in Entrepreneurship Award for 2012
by John Steuart on March 8th, 2012 
March 7, 2012 source: Angel Capital Association (ACA)
AssureRx Health, Inc. Receives 2012 ACA Luis Villalobos Award for Innovation
Angel Capital Association Recognizes Company For Industry-leading Personalized Medicine Solution
Hats off to one of my portfolio companies, AssureRx today received the the 2012 Luis Villalobos Award from the Angel Capital Association (ACA), the trade association of leading angel investment groups in North America. This award recognizes the most ingenious and innovative . . .
→ Read full post: Claremont Creek Ventures portfolio company AssureRx Health wins award for innovation
by John Steuart on March 6th, 2012
On February 22, I had the pleasure of speaking with Douglas Crawford, the associate director of QB3 the California Institute for Quantitative Biosciences in Berkeley –. It was quite exciting to be the first guest on their new podcast, QB3 Bio Entrepreneurship. During our lively hour discussion, I had the opportunity to share my thoughts on the current state of venture capital, my strategies for investing (see the title!), and how entrepreneurs can better . . .
→ Read full post: “Be better, faster and cheaper and if I don’t get cheaper, I don’t invest!”
by John Steuart on August 29th, 2011 
Successful venture capital investing in molecular diagnostics requires proper commercialization of innovation. But how does this innovation get brought to market? The panel will explore the challenges of commercialization in a still-difficult business environment.
These challenges include the cost-efficient development of technology that is truly disruptive yet cost-competitive. Panelists will discuss how to best determine the size of a market and how to assess a competitive landscape.
Startups that surmount these challenges then have . . .
→ Read full post: Sam Colella of Versant Ventures, Risa Stack of Kleiner Perkins and Alex de Winter of Mohr Davidow join me for the Molecular Diagnostics World Congress Event on September 29 at 5:15pm
by John Steuart on July 22nd, 2011
I will be moderating a panel, Venture Capitalists’ Best Practices on Commercializing Innovation at the Molecular Diagnostics World Congress on September 29, 2011 at the South San Francisco Conference Center.
Here’s the panel topic summary, hope to see you there.
Successful venture capital investing in molecular diagnostics requires proper commercialization of innovation. But how does this innovation get brought to market? The panel will explore the challenges of commercialization in a still-difficult business environment. These . . .
→ Read full post: Molecular Diagnostics World Congress, Venture Capitalists’ Best Practices on Commercializing Innovation
John Steuart was a panelist at The Deal’s webcast audio seminar:
Technology Transfer in the 21st Century, on May 12, 2011
(also participating as a panelist – Jeff Jensen, CEO, Fluxion Biosciences Inc. a Claremont Creek Ventures portfolio company)
A recording of the seminar is now available to play online or download through 8/12/2011.
Click here to access the recording. The slides from the webcast are . . .
→ Read full post: Recording of “Technology Transfer in the 21st Century” webcast available
|
